Subfoveal geographic atrophy is an advanced form of dry age-related macular degeneration (AMD) in which cells in the center of the retina have been damaged and lost. This damage affects the fovea, the small part of the eye responsible for seeing fine details clearly. It can make everyday activities such as reading, recognizing faces, and driving more difficult.
What Does Subfoveal Geographic Atrophy Mean?
The medical term "subfoveal geographic atrophy" describes both the type of retinal damage and its location. Breaking down the words helps explain what an eye specialist sees during an examination.
- Subfoveal: Refers to a location beneath or involving the fovea, the tiny central area of the macula that provides the sharpest vision.
- Geographic: Describes clearly defined patches of damaged retinal tissue that can be identified on eye imaging.
- Atrophy: Means the thinning, deterioration, or loss of tissue and cells.
In practical terms, subfoveal geographic atrophy means that an area of geographic atrophy involves the central fovea. This location matters because the fovea is essential for seeing small details directly in front of you.
According to the American Society of Retina Specialists, geographic atrophy often begins near the fovea. As the damaged area expands into the fovea, central vision can decline over time.
How Is Subfoveal Geographic Atrophy Different From Non-Subfoveal Atrophy?
Eye specialists distinguish geographic atrophy involving the fovea from geographic atrophy located outside it. Both involve damage to retinal tissue, but the position of that damage can influence how much a person's central vision is affected.
Subfoveal geographic atrophy
In subfoveal geographic atrophy, the damaged area reaches or involves the central fovea. Because this region provides high-detail vision, damage here may have a substantial effect on reading and recognizing fine details.
Non-subfoveal geographic atrophy
In non-subfoveal geographic atrophy, the damaged tissue does not involve the central fovea. A person may retain relatively sharp straight-ahead vision while experiencing difficulty with other parts of their central visual field.
Non-subfoveal atrophy can eventually become subfoveal if the affected retinal area expands into the fovea. However, the rate and pattern of progression differ between individuals.
Why Does the Location of Geographic Atrophy Matter?
The macula is a small region near the center of the retina that helps people see objects clearly when looking directly at them. The fovea lies at the center of the macula and provides particularly detailed vision.
Geographic atrophy develops when light-sensitive retinal cells and the supporting tissues beneath them deteriorate. As these cells are lost, the affected parts of the retina can no longer process visual information normally.
When damage involves the fovea, a person may find it difficult to see fine details even if the surrounding retina continues to function.
The Cleveland Clinic explains that geographic atrophy primarily affects central vision, while peripheral vision is generally preserved. This means a person may still notice objects to the side while struggling to see something directly ahead.
What Vision Changes Can Subfoveal Geographic Atrophy Cause?
Vision changes depend on the location and extent of retinal damage, whether one or both eyes are affected, and the condition of the remaining retinal tissue.
Examples of changes that may occur include:
- Blurry central vision: Objects directly ahead may appear less clear, even with prescription glasses.
- Missing areas of vision: Dark, blank, or unclear patches may appear near the center of sight.
- Difficulty reading: Letters or words may be hard to identify because central details are missing.
- Trouble recognizing faces: Facial features may become difficult to distinguish.
- Reduced vision in dim lighting: Reading or moving between bright and dark environments may become more challenging.
- Difficulty driving: Reduced central detail may interfere with identifying road signs or other important visual information.
These experiences are not unique to geographic atrophy. Other eye conditions can produce similar symptoms, which is why changes in vision should be assessed through a professional eye examination.
How Do Eye Doctors Identify Subfoveal Geographic Atrophy?
Ophthalmologists, particularly retina specialists, use an eye examination and retinal imaging to identify areas of atrophy and determine whether the fovea is involved.
Several tests can help describe the damage accurately.
Optical coherence tomography (OCT)
OCT is a noninvasive imaging test that uses light to create detailed cross-sectional pictures of the retina. It allows specialists to examine the retinal layers and identify structural changes associated with geographic atrophy.
For subfoveal disease, OCT is especially useful because it helps establish whether the central foveal region is affected.
Fundus autofluorescence imaging
Fundus autofluorescence, often shortened to FAF, creates images that help identify and measure areas of retinal pigment epithelium damage.
These images can help doctors document the boundaries of geographic atrophy and compare changes during follow-up visits.
Visual function testing
Standard eye charts measure how clearly a person can identify letters. Additional testing, such as microperimetry, may help evaluate visual sensitivity in specific parts of the macula.
As described by the National Eye Institute, age-related macular degeneration is evaluated through a comprehensive dilated eye examination. Retinal imaging and visual testing can provide further information about the condition.
An eye specialist interprets these findings alongside the person's symptoms, medical history, and previous examination results. The imaging pattern, rather than symptoms alone, establishes whether the atrophy involves the fovea.
How Is the Term Subfoveal Geographic Atrophy Used in Medical Care?
Subfoveal geographic atrophy is a descriptive diagnosis and imaging term, not a separate disease unrelated to macular degeneration. It gives eye specialists important information about the location of retinal damage.
Describing the location of retinal damage
Medical records may classify geographic atrophy as subfoveal or non-subfoveal. This helps clinicians communicate whether the foveal center is affected.
The distinction is useful because two people with similar amounts of geographic atrophy may experience different levels of visual difficulty depending on where the damaged tissue is located.
Monitoring disease progression
Retinal imaging allows specialists to compare the location and size of atrophic areas over time.
Tracking these changes helps show whether the damaged region is expanding and how it relates to the central fovea. This information can support follow-up planning and discussions about vision changes.
Guiding treatment discussions
Whether geographic atrophy involves the fovea can influence the potential benefits and limitations of treatment. Specialists also consider the extent of existing damage, the condition of the other eye, visual function, and treatment risks.
In clinical research, the distinction helps investigators describe participants' retinal findings and evaluate how geographic atrophy progresses in different locations.
Can Subfoveal Geographic Atrophy Be Treated?
Subfoveal geographic atrophy cannot currently be reversed by established treatments. Once retinal tissue has been lost, available medications do not restore the damaged cells or bring back the vision they previously provided.
However, treatment and supportive care may still help manage the condition.
Medications that slow geographic atrophy progression
Two medications, pegcetacoplan (Syfovre) and avacincaptad pegol (Izervay), have been approved by the U.S. Food and Drug Administration to slow the progression of geographic atrophy associated with age-related macular degeneration.
These medications are administered through injections into the eye. They are intended to slow the enlargement of atrophic areas rather than restore vision that has already been lost.
Not every patient is an appropriate candidate for treatment. The decision depends on an individualized assessment of potential benefits, risks, retinal findings, and treatment availability. Eye injections also carry risks, including inflammation and complications affecting vision.
Are AREDS2 supplements useful?
AREDS2 supplements contain a specific combination of vitamins and minerals studied in age-related macular degeneration. Their usefulness depends partly on disease stage and the location of retinal damage.
A 2024 analysis reported by the National Eye Institute found that AREDS2 supplements slowed the expansion of geographic atrophy toward the fovea in some people with late-stage dry AMD. However, the analysis found little benefit when geographic atrophy was already present in central vision.
These findings are particularly relevant when comparing subfoveal and non-subfoveal disease. Supplements should be discussed with an eye specialist rather than used as a substitute for recommended monitoring or treatment.
Living With Central Vision Loss From Geographic Atrophy
Although damage to the fovea can make detailed vision difficult, people with geographic atrophy may still have useful remaining vision.
Low-vision rehabilitation focuses on helping people make better use of that vision during everyday activities.
Depending on individual needs, supportive approaches may include:
- Magnifiers or electronic reading devices to make text easier to see.
- Large-print books, enlarged phone text, and accessibility settings.
- Improved lighting for reading, cooking, and other close-up activities.
- High-contrast labels and household organization to help identify objects.
- Professional low-vision rehabilitation to develop practical strategies for daily tasks.
The National Eye Institute explains that vision rehabilitation and assistive devices can help people with low vision carry out everyday activities more independently.
These approaches do not repair retinal tissue, but they may reduce the practical difficulties caused by central vision loss.
When Should Changes in Vision Be Evaluated?
People with known geographic atrophy should follow the examination schedule recommended by their eye specialist. Follow-up imaging can help monitor retinal changes and support decisions about ongoing care.
New or worsening difficulty reading, recognizing faces, or seeing clearly should be assessed, particularly when the changes interfere with everyday activities.
A sudden change in central vision, new distortion of straight lines, or a rapidly appearing dark spot requires prompt eye evaluation. These changes may have causes other than geographic atrophy, including conditions that need timely treatment.
What Is the Main Significance of Subfoveal Geographic Atrophy?
The most important feature of subfoveal geographic atrophy is its location. It identifies geographic atrophy that has reached the fovea, the part of the retina responsible for the clearest central vision.
This term helps eye specialists describe retinal damage, understand its possible effect on daily vision, monitor progression, and discuss realistic treatment goals.
Although existing tissue loss cannot currently be reversed, appropriate retinal care, treatment discussions, and low-vision support can help people manage the condition and preserve independence.